Overview
Aptadir Therapeutics, a Milan, Italy-based biotech company developing a novel class of RNA inhibitor-based therapeutics for treating intractable genetic conditions, closed a EUR 40M Seed funding round. The round was led by 4BIO Capital, with follow-on participation from original pre-seed investor, EXTEND, Italy’s National Technology Transfer Hub, launched by CDP Venture Capital SGR and jointly funded by Angelini Ventures and Evotec SE. The seed round was also supported by CDP Venture Capital, th...See more
Website
https://www.aptadir.com/Headquarters
Milan, Italy
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
EUR 40,000,000 • Seed
Announced on 9/29/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.